| Product Name | Price | Order link |
| BUY DIPROLENE CREAM ONLINE | ||
| BUY DIPROLENE CREAM ONLINE | ||
| BUY DIPROLENE CREAM ONLINE | ||
| BUY DIPROLENE CREAM ONLINE | ||
| BUY DIPROLENE CREAM ONLINE | ||
| BUY DIPROLENE CREAM ONLINE |
Diprolene AF Drug Uses
Diprolene AF Cream is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older.
VioQuest Pharmaceuticals Submits 510(k) Application to FDA for ... Business Wire (press release), CA - ... a topical skin preparation intended to relieve and to manage the burning and itching associated with various dermatoses including atopic dermatitis, ... |
VioQuest files marketing application for Xyfid Trading Markets (press release), CA - VioQuest's Xyfid is also intended to relieve and manage the burning and itching associated with various dermatoses including atopic dermatitis, ... VioQuest Pharmaceuticals announces submission of application to ... Indevus obtains FDA approvable letter for hypogonadism drug Indevus Pharmaceuticals gets approvable FDA letter for Nebido |
VioQuest Pharmaceuticals Submits 510(k) Application to FDA for ... PharmaLive.com (press release), PA - ... a topical skin preparation intended to relieve and to manage the burning and itching associated with various dermatoses including atopic dermatitis, ... |
2008-07-02 13:41:16 - www.companiesandmarkets.com adds new report ... PR-Inside.com (Pressemitteilung), Austria - ... combinations of approved drugs for the treatment of immuno-inflammatory diseases, chronic pain, topical dermatoses, metabolic disease and oncology. ... |
VioQuest Pharmaceuticals Appoints Christopher P. Schnittker, CPA ... Business Wire (press release), CA - ... for the treatment of dry skin conditions and to manage the burning and itching associated with various dermatoses; VQD-002 (triciribine phosphate ... |
Galderma Announces Approval for Differin(R) Gel 0.1% in Japan MarketWatch - ... fungal nail infections, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancers and medical solutions for skin senescence. ... |
Boehringer Ingelheim To Acquire Actimis Pharmaceuticals Pharmaceutical Online (press release), PA - ... severe respiratory, inflammatory and autoimmune diseases such as asthma, inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. ... |
Glenmark Generics receives ANDA approvals Express Pharma, India - ... is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ... |
How Diprolene AF Taken
Apply a thin film of Diprolene AF Cream to the affected skin areas once or twice daily. Treatment with Diprolene AF Cream should be limited to 45 g per week.
Diprolene AF Warnings/Precautions
This medication is to be used as directed by the physician and should not be used longer than the prescribed time period. It is for external use only. Avoid contact with the eyes. Do not use this medication for any disorder other than that for which it was prescribed. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive.
Missed Diprolene AF Dose
If you miss a dose, use it as soon as you remember. If it is near the time for the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Possible Diprolene AF Side Effects
Adverse reactions reported to be possibly or probably related to treatment with Diprolene AF Cream during a pediatric clinical study include signs of skin atrophy (telangiectasia, bruising, shininess).
Diprolene AF Storage
Store between 2°and 30°C (36° and 86° F).
Diprolene AF Overdose
Topically applied Diprolene AF can be absorbed in sufficient amounts to produce systemic effects. Seek emergency medical attention if an overdose is suspected.
More Diprolene AF Information
Diprolene AF Cream is contraindicated for patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.
Disclaimer
This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information.